• 中文核心期刊要目总览
  • 中国科技核心期刊
  • 中国科学引文数据库(CSCD)
  • 中国科技论文与引文数据库(CSTPCD)
  • 中国学术期刊文摘数据库(CSAD)
  • 中国学术期刊(网络版)(CNKI)
  • 中文科技期刊数据库
  • 万方数据知识服务平台
  • 中国超星期刊域出版平台
  • 国家科技学术期刊开放平台
  • 荷兰文摘与引文数据库(SCOPUS)
  • 日本科学技术振兴机构数据库(JST)

磷酸钙纳米体系用于顺铂前药的运载

Calcium phosphate nanoparticles for the delivery of the prodrug of cisplatin

  • 摘要: 纳米载药体系能促进铂类广谱抗癌药物的运输和增强药效,并保护作为前药的四价铂在到达细胞前不被还原.以磷酸钙纳米颗粒为基础建立了一种生物兼容性高、制备方法简单的四价铂前药运载体系.通过动态光散射、扫描电镜和X射线衍射对颗粒粒径和形貌进行了表征,并研究其细胞摄取效率和细胞毒性.实验结果表明,该纳米载药体系的粒径分布较窄、分散性较好、细胞摄取效率较高,并具有还原响应性,可在胞内还原剂的作用下释放出顺铂,显著提高了四价铂前药对肿瘤细胞的抑制作用.

     

    Abstract: Drug delivery systems can facilitate the delivery of platinum-based drugs, enhance drug efficiency and protect Pt(Ⅳ) from being reduced before cellular uptake. A highly biocompatible Pt(Ⅳ) prodrugs delivery system using calcium phosphate (CaP) nanoparticles with simple preparation procedures were reported. The diameter and morphology of Pt(Ⅳ)/CaP nanoparticles were characterized by dynamic light scattering, scanning electron microscope and X-ray diffraction. Then cellular uptake efficiency and cytotoxicity were studied. The results indicate that nanoparticles are well-dispersive with narrow size distribution; they have high cellular uptake efficiency and redox response so as to release cisplatin after being reduced by cellular reductants. Moreover, the delivery system demonstrates a significantly higher inhibitory effect than the free Pt(Ⅳ) prodrug.

     

/

返回文章
返回